No Quick End To Brexit Activity Hold At EMA
Executive Summary
As the European Medicines Agency gears up to implement its carefully crafted Brexit business continuity plan, it hopes to be in a position to reintroduce some of its currently suspended/reduced activities in the second half of next year.